영인랩플러스

비상장계속사업자

YOUNG IN Labplus Co., Ltd

이순길, 김재우, 이지민

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

영인랩플러스

Business Reg. No. 2118177812 · CEO 이순길, 김재우, 이지민

I.Investment Overview

Target영인랩플러스 (2118177812)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명영인랩플러스
영문명YOUNG IN Labplus Co., Ltd
대표자이순길, 김재우, 이지민
사업자등록번호2118177812
법인등록번호1101110795629
설립일1991.08.01
종업원수90명

V.Workforce

90

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW902.72021994.52022922.82023878.82024976.92025
영업이익100M KRW40.7202141.7202227202312.8202415.52025
순이익100M KRW38.9202134.6202222202310.8202414.82025
Item20252024202320222021
자산총계506.2억원485.5억원513.4억원488.3억원419억원
부채총계143.9억원138.9억원177.9억원174.4억원139억원
자본총계362.4억원346.5억원335.5억원314억원280억원
매출액976.9억원878.8억원922.8억원994.5억원902.7억원
영업이익15.5억원12.8억원27억원41.7억원40.7억원
순이익14.8억원10.8억원22억원34.6억원38.9억원

VII.Financial Ratios

FY2025 basis

1.59%

영업이익률

1.51%

순이익률

2.92%

ROA

4.08%

ROE

39.7%

부채비율

71.58%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

영인랩플러스 투심보고서 | Alpha Lenz